companydata.dkcompanydata.dk

Shire Biotech Denmark ApS: Financial statements 2015

CVR: 33358008

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 9,706,091 and a net result of DKK 668,629 compared with DKK 342,653 the year before. That is an increase of 35.7% compared with the year before. Equity in the 2015 report amounted to DKK 1,571,869. The solvency ratio was 35.4%.

Gross Profit
DKK 9,706,091
Profit/Loss
DKK 668,629
Equity
DKK 1,571,869
Total Assets
DKK 4,444,438

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-9.7M669K1.6M-
2014-7.2M343K903K-
2013-4.8M232K561K-
20124.1M4.1M93K329K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Shire Biotech Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

Shire Biotech Denmark ApS: The 2014 annual report is outMay 29, 2015

Shire Biotech Denmark ApS has published its annual report for 2014. Gross profit came to DKK 7,151,469, and the net result was DKK 342,653.

Paul Michael Blanchfield joins the board of Shire Biotech Denmark ApSApr 27, 2015

As of April 27, 2015, Paul Michael Blanchfield has joined the board of directors of Shire Biotech Denmark ApS.

Jasper Sökeland joins the board of Shire Biotech Denmark ApSApr 27, 2015

As of April 27, 2015, Jasper Sökeland has joined the board of directors of Shire Biotech Denmark ApS.

John Erik Mattias Bankel leaves the board of Shire Biotech Denmark ApSApr 27, 2015

As of April 27, 2015, John Erik Mattias Bankel has left the board of directors of Shire Biotech Denmark ApS.

Helen Rosemary Janaway leaves the board of Shire Biotech Denmark ApSApr 27, 2015

As of April 27, 2015, Helen Rosemary Janaway has left the board of directors of Shire Biotech Denmark ApS.

Paul Michael Blanchfield joins Shire Biotech Denmark ApS as directorApr 27, 2015

As of April 27, 2015, Paul Michael Blanchfield is registered as director of Shire Biotech Denmark ApS.

John Erik Mattias Bankel steps down as direktion of Shire Biotech Denmark ApSApr 27, 2015

As of April 27, 2015, John Erik Mattias Bankel has stepped down as direktion of Shire Biotech Denmark ApS.

About Shire Biotech Denmark ApS

Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company has been dissolved on 1 April 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SHIRE DENMARK ApS and ApS STAKE NR. 1347. The company has 0 employees (2018). In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity in the 2017 report amounted to DKK 3,207,794.

Source: annual report 2017, Danish Business Authority

Other financial years